LP
Liminatus Pharma, Inc.
SEC filingPharmaceuticals · Fullerton, CA
Amount raised$1.9Msold at filing
Total offering$1.9M
Investors in the raise1count reported to the SEC
FiledJun 18, 2026first sale Jun 3, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Nicholas Sook FernandezDirector
Ji Yeon BaekDirector
Byong C. YooExecutive Officer
Chris KimExecutive Officer, Director
Eun Sook LeeDirector
Sang-jin Daniel LeeExecutive Officer
Scott DamExecutive Officer
Beom K. ChoiExecutive Officer
Executive officers, directors and promoters as listed on the Form D.